Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer

E-ISSN： 1873-4286|24|23|2710-2718

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.23, 2018-06, pp. : 2710-2718

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetic determinants of anti-cancer drug activity and toxicity

By Danesi R. De Braud F. Fogli S. Di Paolo A. Del Tacca M.

Trends in Pharmacological Sciences, Vol. 22, Iss. 8, 2001-08 ,pp. : 420-426

Elsevier

Access to resources Recommend Favorite

Pharmacogenetics of colorectal cancer

By Marsh Sharon

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2607-2616

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics in colorectal cancer: a systematic review

By Funke Silvia Brenner Hermann Chang-Claude Jenny

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1079-1099

Future Medicine

Access to resources Recommend Favorite

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong Tan Cindy Rittau Anneliese Xu Hongmei McLachlan Andrew J Clarke Stephen J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of folate-related drug targets in cancer treatment

By Robien Kim Boynton Alanna Ulrich Cornelia M

Pharmacogenomics, Vol. 6, Iss. 7, 2005-10 ,pp. : 673-689

Future Medicine

Access to resources Recommend Favorite